{"DataElement":{"publicId":"3745016","version":"1","preferredName":"Lung Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Distant Metastasis M Stage","preferredDefinition":"Extent of the distant metastasis for the lung carcinoma based on evidence obtained from pathologic examination through completion of definitive surgery.","longName":"2188861v1.0:3744956v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2188861","version":"1","preferredName":"Lung Tumor Pathologic M Stage","preferredDefinition":"Information related to pathologic M stage of a lung tumor.","longName":"LUNG_TUMOR_P_M_ST","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206550","version":"1","preferredName":"Lung Neoplasm","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12468:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F968-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207807","version":"1","preferredName":"Pathologic M Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25610:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30F5-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5B41B0A-17D7-6F05-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-05","modifiedBy":"TAYLORT","dateModified":"2017-09-13","changeDescription":"9/13/17 tt transferred context; changed def - 1st letter upper case; changed Reg Status to Qualified.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3744956","version":"1","preferredName":"Lung Cancer American Joint Committee on Cancer Edition 7 Pathologic M Stage","preferredDefinition":"A pathologic finding about one or more characteristics of lung cancer, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.  There is no pathologic M0 for lung cancer. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3744956v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"M1b","valueDescription":"Lung Cancer pM1b TNM Finding v7","ValueMeaning":{"publicId":"3744958","version":"1","preferredName":"Lung Cancer pM1b TNM Finding v7","longName":"3744958","preferredDefinition":"Distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pM1b TNM Finding v7","conceptCode":"C88881","definition":"Distant metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC229CEB-DB93-AB2A-E040-BB89AD432F0C","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC229CEB-DBAC-AB2A-E040-BB89AD432F0C","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"},{"value":"M1a","valueDescription":"Lung Cancer pM1a TNM Finding v7","ValueMeaning":{"publicId":"3744960","version":"1","preferredName":"Lung Cancer pM1a TNM Finding v7","longName":"3744960","preferredDefinition":"Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural (or pericardial) effusion.  Most pleural (and pericardial) effusions with lung cancer are due to tumor.  In a few patients, however, multiple cytopathologic examinations of pleural (or pericardial) fluid) are negative for tumor, and the fluid is nonbloody and is not an exudate.  Where these elements and clinical judgment dictate that the effusion is not related to the tumor, the effusion should be excluded as a staging element and the patient should be classified as M0. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pM1a TNM Finding v7","conceptCode":"C88880","definition":"Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural (or pericardial) effusion.  Most pleural (and pericardial) effusions with lung cancer are due to tumor.  In a few patients, however, multiple cytopathologic examinations of pleural (or pericardial) fluid) are negative for tumor, and the fluid is nonbloody and is not an exudate.  Where these elements and clinical judgment dictate that the effusion is not related to the tumor, the effusion should be excluded as a staging element and the patient should be classified as M0. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC229CEB-DBB9-AB2A-E040-BB89AD432F0C","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC229CEB-DBD2-AB2A-E040-BB89AD432F0C","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"},{"value":"M1","valueDescription":"Lung Cancer pM1 TNM Finding v7","ValueMeaning":{"publicId":"3744962","version":"1","preferredName":"Lung Cancer pM1 TNM Finding v7","longName":"3744962","preferredDefinition":"Lung cancer with distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pM1 TNM Finding v7","conceptCode":"C88879","definition":"Lung cancer with distant metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC229CEB-DBDF-AB2A-E040-BB89AD432F0C","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC229CEB-DBF8-AB2A-E040-BB89AD432F0C","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3744955","version":"1","preferredName":"Lung Cancer Pathologic Distant Metastasis TNM Finding v7 American Joint Committee on Cancer Stage","preferredDefinition":"A pathologic finding about one or more characteristics of lung cancer, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.  There is no pathologic M0 for lung cancer. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C88878:C39315:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer Pathologic Distant Metastasis TNM Finding v7","conceptCode":"C88878","definition":"A pathologic finding about one or more characteristics of lung cancer, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.  There is no pathologic M0 for lung cancer. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC229CEB-DB67-AB2A-E040-BB89AD432F0C","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC229CEB-DB78-AB2A-E040-BB89AD432F0C","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"COOPERM","dateModified":"2014-01-17","changeDescription":"Created for CRF Harmonization per request D.Reeves for Duke U. mc 5/6/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3744891","version":"1","longName":"Lung (Non-Small Cell)","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736425","version":"1","longName":"Lung Local Path Review","context":"BBRB"}]},{"publicId":"5506111","version":"1","longName":"Lung","context":"MCL","ClassificationSchemeItems":[{"publicId":"5506169","version":"1","longName":"Lung-Vanderbilt","context":"MCL"},{"publicId":"5506172","version":"1","longName":"Clinical","context":"MCL"},{"publicId":"7781146","version":"1","longName":"Lung PCA Pilot","context":"MCL"},{"publicId":"5858017","version":"1","longName":"Lung Core","context":"MCL"}]},{"publicId":"5506115","version":"1","longName":"Imaging","context":"MCL","ClassificationSchemeItems":[{"publicId":"5983666","version":"1","longName":"Vanderbilt Image Archive","context":"MCL"}]},{"publicId":"5506116","version":"1","longName":"Pathology","context":"MCL","ClassificationSchemeItems":[{"publicId":"5855641","version":"1","longName":"Lung Pathology","context":"MCL"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777523","version":"1","longName":"Lung-NSC","context":"NCI Standards"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001792","version":"1","longName":"Lung PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"2188861v1.0:3744956v1.0","type":"USED_BY","context":"Alliance"},{"name":"BBRB","type":"USED_BY","context":"BBRB"},{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"ajcc_7_lung_pathologic_m","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Pathologic M Stage","type":"Preferred Question Text","description":"Pathologic M Stage","url":null,"context":"NCI Standards"},{"name":"No Pathologic M0","type":"NOTE","description":"No pathologic M0; use clinical M to complete stage group","url":null,"context":"NCIP"},{"name":"Information Related to Stage M1a","type":"COMMENT","description":"Most pleural (and pericardial) effusions with lung cancer are due to tumor. In a few patients, however, multiple cytopathologic examinations of pleural (pericardial) fluid are negative for tumor, and the fluid is nonbloody and is not an exudate. Where these elements and clinical judgement dictate that the effusion is not related to the tumor, the effusion should be excluded as a staging element and the patient should be classified as M0.","url":null,"context":"NCIP"},{"name":"BPV_GTEx","type":"BBRB Text","description":"M: Distant Metastases (AJCC 7th Edition)","url":null,"context":"BBRB"},{"name":"MCL Path-1","type":"Alternate Question Text","description":"Path TNM Class M","url":null,"context":"MCL"},{"name":"MCL-PCA-1","type":"Alternate Question Text","description":"Path TNM Class M","url":null,"context":"MCL"},{"name":"MCL-Lung-1","type":"Alternate Question Text","description":"Path TNM Class M","url":null,"context":"MCL"},{"name":"MCL-PCA-Lung-1","type":"Alternate Question Text","description":"American Joint Committee on Cancer metastasis stage code","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"lung_v0_2021_08_25-metrics.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"DC244A63-8B96-AF4B-E040-BB89AD4329B6","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeDescription":"9/9/21 mr Added alt name, AQT, alt def, ref doc, and CSI for MCL Lung Core. Per MCL DD.  5/18/16 jk moved from EDRN to MCL context CSI.  5/7/13 Created for CRF Harmonization per request by D.Reeves for Duke U. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}